tirzepatide and hrt together Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Hormone therapy supercharges weight loss

As interest in longevity medicine grows, BPC-157 peptide therapy is emerging as a compelling option for patients seeking to address pain, inflammation, and tissue recovery through science-backed regenerative means

doi: 10.1038/s41575-018-0009-6 24 YuanNShenLPengQShaRWangZXieZet al

What it does cause is a temporary increase in resting heart rate

Besides, regions corresponding to transit peptide sites in APX/GPX sequences did not demonstrate any particular pattern, indicating the less conserved structure of transit peptides thereby the functional diversities of APXs/GPXs at various targets

It strengthens Novo Nordisks dominance in the GLP-1 class and could reshape treatment algorithms, challenging SGLT2 inhibitors and injectable GLP-1s in early CV risk management

Preconditioning with Maillard reaction products improves antioxidant defence leading to increased stress tolerance in cardiac cells